Meeting
2014 ASCO Annual Meeting
ABCB1 polymorphism as a prognostic factor in breast cancer patients with neoadjuvant chemotherapy.
Authors
Hee Jun Kim
Chung-Ang University Hospital, Seoul, South Korea
Hee Jun Kim , Seock-Ah Im , Hye Seon Ham , Kyung Hun Lee , Tae Yong Kim , Yu Jeong Kim , Do-Youn Oh , Jee Hyun Kim , Wonshik Han , In-Jin Jang , Tae-You Kim , In Ae Park , Dong Young Noh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Cytotoxic Chemotherapy
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 1038)
DOI
10.1200/jco.2014.32.15_suppl.1038
Abstract #
1038
Poster Bd #
131
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
A prospective randomized controlled trial of hydrating nail solution for prevention or treatment of onycholysis in breast cancer patients who received neoadjuvant/adjuvant docetaxel chemotherapy.
First Author: Ji-Yeon Kim
Poster
2015 ASCO Annual Meeting
Mechanistic and clinical analysis of Sperm associated antigen 5 (SPAG5) as a novel prognostic, predictive, actionable gene in Breast Cancer (BC).
First Author: Tarek M. A. Abdel-Fatah
Poster
2021 ASCO Quality Care Symposium
Association of primary prophylactic (PP) granulocyte-colony stimulating factor (G-CSF) use with chemotherapy dose modifications and relative dose intensity (RDI) among breast cancer patients receiving high-risk regimens for febrile neutropenia (FN).
First Author: Jaime Shaw
Poster
2017 ASCO Annual Meeting
Chemotherapy-induced ovarian failure (CIOF) in young women with early breast cancer (EBC).
First Author: Jenny Furlanetto